Remove Pharma Companies Remove Production Remove Research Remove Research Analyst
article thumbnail

Risk sharing agreements soar as market access risk increases

Pharmaceutical Technology

Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex Watt, GlobalData’s principal research analyst, at a recent webinar on the same topic. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies.

Marketing 257